Changlin Zhou
Impact in
- Microbiology top 1%
- Antimicrobial Peptides and Activities
- Pharmacology top 2%
- Flavonoids in Medical Research
- Pharmacological Effects of Natural Compounds
Papers in
- Microbiology 27
- Antimicrobial Peptides and Activities 25
- Immunology 23
- Immune Response and Inflammation 8
- interferon and immune responses 5
- Co-authors
- Jie DouQinglong GuoYiran ZhouHui WangLingman MaBaiyong ShenYinsheng WanTao Xi
- Journals
- Frontiers in Pharmacology (5 papers)International Journal of Oncology (4 papers)World Journal of Microbiology and Biotechnology (3 papers)Peptides (3 papers)Archives of Pharmacal Research (3 papers)
- Partner nations
- ChinaUnited StatesNetherlands
In The Last Decade
Changlin Zhou
106 papers receiving 2.9k citations
Peers
Comparison fields: 5 of 124
- Microbiology 376
- Pharmacology 262
- Pharmacology 436
- Molecular Biology 1.6k
- Complementary and alternative medicine 169
Countries citing papers authored by Changlin Zhou
This map shows the geographic impact of Changlin Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changlin Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changlin Zhou more than expected).
Fields of papers citing papers by Changlin Zhou
This network shows the impact of papers produced by Changlin Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changlin Zhou. The network helps show where Changlin Zhou may publish in the future.
Co-authors
The 25 scholars most cited alongside Changlin Zhou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 0 | |
| 2 | 2023 | 7 | |
| 3 | 2022 | 7 | |
| 4 | 2021 | 4 | |
| 5 | 2020 | 30 | |
| 6 | 2020 | 76 | |
| 7 | MicroRNA-145 inhibits growth of laryngeal squamous cell carcinoma by targeting the PI3K/Akt signaling pathway | 2019 | 1 |
| 8 | 2018 | 104 | |
| 9 | 2017 | 29 | |
| 10 | 2017 | 22 | |
| 11 | 2016 | 19 | |
| 12 | Research on Degradation of Type 9V Pneumococcal Capsular Polysaccharide | 2013 | 1 |
| 13 | 2013 | 51 | |
| 14 | 2009 | 20 | |
| 15 | Separation,purification and activity of pharmacodynamic action of polysaccharide from Cordyceps | 2008 | 1 |
| 16 | 2008 | 12 | |
| 17 | Effects of glycerol on recombinant hirudin II expression in high density fermentation by Pichia pastoris | 2006 | 1 |
| 18 | 2006 | 73 | |
| 19 | Studies on the culture and applicayion of a nitrite--oxidizing bacterium with high nitrification activity | 2005 | 2 |
| 20 | Application of Microbial Transformation in Medicine Metabolization Model in vitro by Cunninghammella Matruchot | 2004 | 1 |
About Changlin Zhou
Changlin Zhou is a scholar working on Microbiology, Immunology, Pharmacology, Molecular Biology and Molecular Medicine, having authored 108 papers that have together received 2.9k indexed citations. Recurring topics across this work include Antimicrobial Peptides and Activities (25 papers), Biochemical and Structural Characterization (11 papers), Influenza Virus Research Studies (8 papers), Immune Response and Inflammation (8 papers), Flavonoids in Medical Research (7 papers), Fungal Biology and Applications (6 papers), interferon and immune responses (5 papers) and Natural product bioactivities and synthesis (5 papers). The work is most often cited by research in Microbiology (376 citations), Pharmacology (262 citations), Pharmacology (436 citations), Molecular Biology (1.6k citations) and Complementary and alternative medicine (169 citations). Changlin Zhou has collaborated with scholars based in China, United States and Netherlands. Frequent co-authors include Jie Dou, Qinglong Guo, Yiran Zhou, Hui Wang, Lingman Ma, Baiyong Shen, Yinsheng Wan, Lingman Ma, Tao Xi and Ke Mao. Their work appears in journals such as Frontiers in Pharmacology, International Journal of Oncology, World Journal of Microbiology and Biotechnology, Peptides and Archives of Pharmacal Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.